The Role This role will support Oncology Therapeutic programs, specifically supporting the Clinical Study Lead in the development, execution and evaluation of Phase 1-3 clinical studies. The principal responsibility for this role is to ensure the
Alnylam Pharmaceuticals is seeking an imaginative physician drug developer in Clinical Research - Cardiovascular & Metabolism (CVM) therapeutic area, also with the flexibility and confidence to work in therapeutic areas that may be beyond their expertise
ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster. As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart